(NASDAQ: NAGE) Niagen Bioscience's forecast annual revenue growth rate of 20.03% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 144.89%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.59%.
Niagen Bioscience's revenue in 2025 is $99,597,000.On average, 2 Wall Street analysts forecast NAGE's revenue for 2025 to be $9,256,190,715, with the lowest NAGE revenue forecast at $9,174,552,746, and the highest NAGE revenue forecast at $9,337,828,685. On average, 2 Wall Street analysts forecast NAGE's revenue for 2026 to be $11,219,389,502, with the lowest NAGE revenue forecast at $11,164,964,189, and the highest NAGE revenue forecast at $11,273,814,815.
In 2027, NAGE is forecast to generate $12,960,999,515 in revenue, with the lowest revenue forecast at $12,960,999,515 and the highest revenue forecast at $12,960,999,515.